Skip to main content
SpringerLink
Log in

Sofosbuvir

Hepatitis B virus reactivation and appearence of detectable residual Hepatitis B virus DNA: 4 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Ogawa E, et al. Potential risk of HBV reactivation in patients with resolved HBV infection undergoing direct-acting antiviral treatment for HCV. Liver International 38: 76-83, No. 1, Jan 2018. Available from: URL: http://doi.org/10.1111/liv.13496 - Japan

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sofosbuvir. Reactions Weekly 1736, 179 (2019). https://doi.org/10.1007/s40278-019-57072-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-57072-5

Search

Navigation